Device Trial Radar · NCT06032078
Evaluation of the Responsiveness of Investigator Global Assessment Score for Keratosis Pilaris
Last checked: Nov 19, 2026Latest source record: Sep 11, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
15
Planned (sponsor's estimate)
Start
Jul 26, 2023
Primary completion
Dec 29, 2023
Study completion Dec 29, 2023
Sponsor
- Lead sponsor
- Premier Specialists, AustraliaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- The University of New South Wales
- First posted
- Sep 11, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This prospective study aims to evaluate the responsiveness of the validated investigator global assessment (IGA) and composite area index score for keratosis pilaris by data collection through treatment and scoring sessions held at a private practice and relevant statistical analysis.
Conditions
- Keratosis Pilaris
Interventions
Cutera laser machineDevice
1064nm Nd: YAG laser
Primary outcomes
What the sponsor says the trial is designed to measure.
- KP-IGATime frame: through study completion, an average of 1 year
- KPAITime frame: through study completion, an average of 1 year
- Likert Scale of Magnitude of CHangeTime frame: through study completion, an average of 1 year
1 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Premier Dermatology
Sydney, New South Wales, Australia
Premier Specialists
Sydney, New South Wales, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.